Effect of dexmedetomidine on lung ischemia-reperfusion injury

Molecular Medicine Reports

Volumn 9, Issue 2, 2014, Pages 419-426

  Jiang, Lili ^a   Li, Li ^a   Shen, Jinmei ^a   Qi, Zeyou ^a   Guo, Liang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Dexmedetomidine; Interleukin 6; Ischemia reperfusion injury; Tumor necrosis factor

Indexed keywords

ANIMALS; BRONCHOALVEOLAR LAVAGE; DEXMEDETOMIDINE; INTERLEUKIN-6; LUNG; LUNG INJURY; MITOGEN-ACTIVATED PROTEIN KINASES; MYELOID DIFFERENTIATION FACTOR 88; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893860408     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1867     Document Type: Article

References (42)

1. Christie JD, Carby M, Bag R, Corris P, Hertz M and Weill D; ISHLT Working Group on Primary Lung Graft Dysfunction: Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24: 1454-1459, 2005.
2. Ng CS, Wan S, Yim AP and Arifi AA: Pulmonary dysfunction after cardiac surgery. Chest 121: 1269-1277, 2002.
3. Shimamoto A, Pohlman TH, Shomura S, Tarukawa T, Takao M and Shimpo H: Toll-like receptor 4 mediates lung ischemia-reperfusion injury. Ann Thorac Surg 82: 2017-2023, 2006.
4. Ambrosio G and Tritto I: Reperfusion injury: experimental evidence and clinical implications. Am Heart J 138: S69-S75, 1999.
5. Reino DC, Pisarenko V, Palange D, et al: Trauma hemorrhagic shock-induced lung injury involves a gut-lymph-induced TLR4 pathway in mice. PLoS One 6: e14829, 2011.
6. Zhao M, Fernandez LG, Doctor A, et al: Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 291: L1018-L1026, 2006.
7. Gu J, Chen J, Xia P, Tao G, Zhao H and Ma D: Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice. Acta Anaesthesiol Scand 55: 1272-1278, 2011.
8. Taniguchi T, Kidani Y, Kanakura H, Takemoto Y and Yamamoto K: Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 32: 1322-1326, 2004.
9. Memiş D, Hekimoǧlu S, Vatan I, Yandim T, Yüksel M and Süt N: Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth 98: 550-552, 2007.
10. Yang CL, Tsai PS and Huang CJ: Effects of dexmedetomidine on regulating pulmonary inflammation in a rat model of ventilator-induced lung injury. Acta Anaesthesiol Taiwan 46: 151-159, 2008.
11. Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM and Woodruff TM: Toll-like receptors in ischemia-reperfusion injury. Shock 32: 4-16, 2009.
12. Prakash A, Mesa KR, Wilhelmsen K, Xu F, Dodd-o JM and Hellman J: Alveolar macrophages and Toll-like receptor 4 mediate ventilated lung ischemia reperfusion injury in mice. Anesthesiology 117: 822-835, 2012.
13. Shi QQ, Wang H and Fang H: Dose-response and mechanism of protective functions of selective alpha-2 agonist dexmedetomidine on acute lung injury in rats. Saudi Med J 33: 375-381, 2012.
14. Yang CL, Chen CH, Tsai PS, Wang TY and Huang CJ: Protective effects of dexmedetomidine-ketamine combination against ventilator-induced lung injury in endotoxemia rats. J Surg Res 167: e273-e281, 2011.
15. Yang CH, Tsai PS, Wang TY and Huang CJ: Dexmedetomidine-ketamine combination mitigates acute lung injury in haemorrhagic shock rats. Resuscitation 80: 1204-1210, 2009.
16. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
17. Emaminia A, Lapar DJ, Zhao Y, et al: Adenosine A2A agonist improves lung function during ex vivo lung perfusion. Ann Thorac Surg 92: 1840-1846, 2011.
18. Guo W, Ge D, Wang Q, et al: Diazoxide decreases ischemia-reperfusion injury in a rat model of lung transplantation. Transplant Proc 43: 2510-2516, 2011.
19. Jan WC, Chen CH, Tsai PS and Huang CJ: Limb ischemic preconditioning mitigates lung injury induced by haemorrhagic shock/resuscitation in rats. Resuscitation 82: 760-766, 2011.
20. Xu B, Gao X, Xu J, et al: Ischemic postconditioning attenuates lung reperfusion injury and reduces systemic proinflammatory cytokine release via heme oxygenase. J Surg Res 166: e157-e164, 2011
21. Dahmani S, Rouelle D, Gressens P and Mantz J: Characterization of the postconditioning effect of dexmedetomidine in mouse organotypic hippocampal slice cultures exposed to oxygen and glucose deprivation. Anesthesiology 112: 373-383, 2010.
22. Hoffman WE, Kochs E, Werner C, Thomas C and Albrecht RF: Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology 75: 328-332, 1991.
23. Eser O, Fidan H, Sahin O, et al: The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res 1218: 250-256, 2008.
24. Cosar M, Eser O, Fidan H, et al: The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. Surg Neurol 71: 54-59, 2009.
25. Nishina K, Akamatsu H, Mikawa K, et al: The effects of clonidine and dexmedetomidine on human neutrophil functions. Anesth Analg 88: 452-458, 1999.
26. Tasdogan M, Memis D, Sut N and Yuksel M: Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. J Clin Anesth 21: 394-400, 2009.
27. Taniguchi T, Kurita A, Kobayashi K, Yamamoto K and Inaba H: Dose-and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth 22: 221-228, 2008.
28. Sezer A, Memiş D, Usta U and Süt N: The effect of dexmedetomidine on liver histopathology in a rat sepsis model: an experimental pilot study. Ulus Travma Acil Cerrahi Derg 16: 108-112, 2010.
29. Qiao H, Sanders RD, Ma D, Wu X and Maze M: Sedation improves early outcome in severely septic Sprague Dawley rats. Crit Care 13: R136, 2009.
30. Arslan F, Keogh B, McGuirk P and Parker AE: TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm 2010: 704202, 2010.
31. Li Y, Xiang M, Yuan Y, et al: Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. Am J Physiol Regul Integr Comp Physiol 297: R1670-R1680, 2009.
32. Fan J, Li Y, Vodovotz Y, Billiar TR and Wilson MA: Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. Am J Physiol Lung Cell Mol Physiol 290: L738-L746, 2006.
33. Gao Y, Fang X, Sun H, et al: Toll-like receptor 4-mediated myeloid differentiation factor 88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in hippocampal CA1 region in mice. Biol Pharm Bull 32: 1665-1671, 2009.
34. Feng Y, Zhao H, Xu X, et al: Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol 295: H1311-H1318, 2008.
35. Hua F, Ha T, Ma J, et al: Blocking the MyD88-dependent pathway protects the myocardium from ischemia/reperfusion injury in rat hearts. Biochem Biophys Res Commun 338: 1118-1125, 2005.
36. Wang S, Schmaderer C, Kiss E, et al: Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88-and TRIF-dependent signaling. Dis Model Mech 3: 92-103, 2010.
37. Wu H, Chen G, Wyburn KR, et al: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859, 2007.
38. Ben DF, Yu XY, Ji GY, et al: TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion. J Surg Res 174: 326-333, 2012.
39. Zanotti G, Casiraghi M, Abano JB, et al: Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema. Am J Physiol Lung Cell Mol Physiol 297: L52-L63, 2009.
40. Dahmani S, Paris A, Jannier V, et al: Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors. Anesthesiology 108: 457-466, 2008.
41. Zhang F, Ding T, Yu L, Zhong Y, Dai H and Yan M: Dexmedetomidine protects against oxygen-glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K/AKT pathway in rat C6 glioma cells. J Pharm Pharmacol 64: 120-127, 2012.
42. Afonso J and Reis F: Dexmedetomidine: current role in anesthesia and intensive care. Rev Bras Anestesiol 62: 118-133, 2012.